Key result
Heart transplant recipients show ~29-point higher day-to-day wearable ECG T-wave variability than controls.
Why the study?
Little is known about the impact of heart transplantation on wearable ECG recordings or how longitudinal variations in ECG parameters compare with those of healthy individuals.
Does long-term daily wearable ECG analysis detect differences in day-to-day ECG parameter variability in post-heart transplant patients compared to healthy controls?
Observational (n=12)
Does long-term daily wearable ECG analysis detect differences in day-to-day ECG parameter variability in post-heart transplant patients compared to healthy controls?
Wearable-based daily ECG monitoring is feasible in heart transplant recipients and reveals significantly greater day-to-day variability in T-wave, P-wave, and RT-interval parameters compared to healthy controls.
Answers are grounded in this paper and cite their sources.
Greater ECG variability post-transplant supports wearable feasibility; leaves open its role in surveillance pending validation.
Background Wearables are becoming increasingly important in modern cardiology and provide a simple way to monitor high-risk patients such as heart transplant recipients via reliable ECG recordings. However, there is yet little information about the impact of heart transplantation (HTX) on wearable ECG recordings or about possible variations in different ECG parameters compared with healthy individuals. Purpose Investigation of long-term wearable ECG recordings in HTX patients and healthy subjects, including comparison of mean values and longitudinal fluctuations of ECG parameters. Methods Single-lead Apple Watch ECGs were recorded over a period of 30 days in six post-HTX patients (some directly after HTX, i.e., <3 months, and some >3 months after HTX) and six healthy subjects. A template-matching quality control algorithm was used, and peaks and onsets/offsets of waves were detected with the NeuroKit2 algorithm. The amplitude and duration of the R wave, P wave, and T wave, as well as the duration of the PR and RT intervals, were examined. Here, we focused on the analysis of relative changes for mean amplitude/duration for each parameter from the previous day to assess subtle intraindividual changes over time. We used a mixed model to handle repeated measures while in the figures, the entire dataset was used for a clearer presentation Results An exemplary direct comparison between an HTX patient (Figure A) and a healthy subject (Figure B) shows that the absolute values of the two individuals differ markedly. Clear differences were also observed in the percentage deviation from the previous day: the HTX patient showed relative T-wave deviations of approximately 100%, whereas the healthy subject showed deviations of only about 20%. Figures C–J show the percentage day-to-day changes of various ECG parameters in comparison between post-HTX patients and healthy subjects. Significant differences were found in the T-wave amplitude (p=0.002, mean ± SD (HTX resp. Healthy)=49.7±30.4% resp. 20.9%±9.4%), as well as in the duration of the P-wave (p=0.010, 15.3%±10.4% resp. 8.1%±4.2%), T-wave duration (p=0.001, 29.0%±25.3% resp. 7.3%±3.7%) and RT-interval duration (p=0.003, 36.7%±50.3% resp. 5.8%±2.9%). There were no differences in the changes of the P-wave amplitude (p=0.989), R-wave amplitude (p=0.304) and the duration of the R-wave (p=0.103) and PR interval (p=0.591). Conclusion Our analysis shows that it is feasible and reliable to measure and automatically analyze wearable-based daily ECG-recordings. Post-HTX patients show greater day-to-day variability of ECG parameters, this could also allow for close monitoring of intraindividual changes in cardiac conduction properties and offer a sensitive and broadly available tool for the surveillance of cardiac high-risk patients. The next planned step will be a correlation of the daily changes with clinically significant events, such as transplant rejection episodes in our patient cohort.
No takes yet. Share an insight, caveat, or question.
Muggendorfer et al. (2026) conducted an observational in Heart transplantation (n=12). Heart transplantation (monitored via daily single-lead Apple Watch ECG) vs. Healthy subjects was evaluated on Day-to-day relative changes in ECG parameters (specifically T-wave amplitude) (p=0.002). Heart transplant recipients showed greater day-to-day wearable ECG variability than healthy controls, including T-wave amplitude and duration.
Synapse has enriched 10 related papers. Consider them for comparative context: